Application no. and date | 20842239.4 (espacenet) (Federated) (European Patent Register), 20201229 | Patent/reg. no. and date | DK/EP 4085251, 20240731 | Publication date | 20221109 | Priority no. and date | EP 20150135, 20200102 | EP pub. no. and date |
EP 4085251 20221109 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | | Inventor | STUBENRAUCH, Kay-Gunnar, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, JORDAN, Gregor, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, STAACK, Roland, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, BRADY, Kevin, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, SCHAEFER, Martin, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE, ROTTACH, Sylvia, c/o Roche Diagnostics GmbH Nonnenwald 2
82377 Penzberg, DE | Representative | | Opponent | | IPC Class | G01N 33/50 (2006.01) | Title | METHOD FOR DETERMINING THE AMOUNT OF A THERAPEUTIC ANTIBODY IN THE BRAIN | Int. application no. | EP2020087965 | Int. publication no. | WO2021136772 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|